Dr. Laszlo Mechtler is Professor of Neurology and Oncology at the State University of New York at Buffalo, Chief Medical Officer of the Dent Neurologic Institute, the largest out-patient neuroscience center in the United States and as the Chief of Neurology and Oncology and Roswell Park Cancer Center. He holds board certifications in Neurology, Neuroimaging, Neuro-Oncology and Headache Medicine. His training includes institutions such as MD Anderson, the State University of New York at Buffalo, and Semmelweis University. He is a past president of the American Society of Neuroimaging (ASN) and the Hungarian Medical Association of America (HMAA). He was the guest editor of the 2009, 2014 and 2020 editions of Neurology Clinics on ‘Neuroimaging”. He served on the Executive Committee for BrainPAC through the American Academy of Neurology (AAN).

He currently serves on the Board of Directors for the International Headache Society (IHS) and Genomate Health. Dr. Mechtler has published some of the first major retrospective research trials on Medical Marijuana in headaches and various neurologic disorders. He is the Director of the DENT Cannabis Clinic, which has more than 15,000 patients certified through the NYS MMJ program and continues to grow each day. He has developed medical cannabis formulations (CBD/THC) tailored to specific neurologic disorders including migraine, sleep and anxiety. Dr. Mechtler is also the Founder/Chief Medical Officer for the MIND Institute in Budapest, Hungary. Dr. Mechtler lectures both nationally and internationally and is recognized as a leader in the fields of Neuroimaging, Headache Medicine, Neuro-Oncology, and Medical Cannabis.